Psychometric properties of the Treatment Outcomes Profile (TOP) psychological health scale

Mental Health and Substance Use: Dual Diagnosis

Volumn 6, Issue 2, 2013, Pages 140-149

  Delgadillo, Jaime ^a   Payne, Scott ^b   Gilbody, Simon ^c   Godfrey, Christine ^c  

^a LEEDS COMMUNITY HEALTHCARE NHS TRUST   (United Kingdom)

^b WESTERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Anxiety; Comorbidity; Depression; Mental health; Screening; TOP

Indexed keywords

ARTICLE; COMMON MENTAL DISORDER; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; GOLD STANDARD; MENTAL DISEASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL RATING SCALE; RATING SCALE; SEVERITY OF DEPENDENCE SCALE; TREATMENT OUTCOMES PROFILE; UNITED KINGDOM;

EID: 84875947657     PISSN: 17523281     EISSN: 17523273     Source Type: Journal    
DOI: 10.1080/17523281.2012.693521     Document Type: Article

References (35)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: APA.
2. Chang, C-H. (2007). Patient-reported outcomes measurement and management with innovative methodologies and technologies. Quality of Life Research, 16, 157-166.
3. Cleary, M., Hunt, G.E., Matheson, S.L., Siegfried, N., & Walter, G. (2008). Psychosocial interventions for people with both severe mental illness and substance misuse (Review).
4. Cochrane Database of Systematic Reviews 2008, Issue 1. doi: 10.1002/14651858.CD001088.pub2.
5. Cohen, J. (1988). Statistical power analysis for the behavioural sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
6. Cook, N.R. (2007). Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation, 115, 928-935.
7. Delgadillo, J., Payne, S., Gilbody, S., Godfrey, C., Gore, S., Jessop, D., & Dale, V. (2011). How reliable is depression screening in alcohol and drug users? A validation of brief and ultra-brief questionnaires. Journal of Affective Disorders, 134, 266-271.
8. Delgadillo, J., Payne, S., Gilbody, S., Godfrey, C., Gore, S., Jessop, D., & Dale, V. (2012a). Brief case finding tools for anxiety disorders: Validation of GAD-7 and GAD-2 in addictions treatment. Drug and Alcohol Dependence. Advance online publication. doi: 10.1016/j.drugalcdep.2012.03.011
9. Delgadillo, J., Gore, S., Jessop, D., Payne, S., Singleton, P., & Gilbody, S. (2012b). Acceptability of mental health screening in routine addictions treatment. General Hospital Psychiatry. Advance online publication. doi: 10.1016/j.genhosppsych.2012.01.006
10. Department of Health. (2007). Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health (England).
11. Evans, C., Margison, F., & Barkham, M. (1998). The contribution of reliable and clinically significant change methods to evidence-based mental health. Evidence Based Mental Health, 1, 70-72.
12. Fals-Stewart, W., O'Farrell, T.J., Freitas, T.T., McFarlin, S.K., & Rutigliano, P. (2000). The timeline followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties. Journal of Consulting and Clinical Psychology, 68, 134-144.
13. Flahault, A., Cadilhac, M., & Thomas, G. (2005). Sample size calculation should be performed for design accuracy in diagnostic test studies. Clinical Epidemiology, 58, 859-562.
14. Gilbody, S.M., House, A.O., & Sheldon, T.A. (2001). Routinely administered questionnaires for depression and anxiety: Systematic review. British Medical Journal, 322, 406-409.
15. Gilchrist, G., Gruer, L., & Atkinson, J. (2005). Comparison of drug use and psychiatric morbidity between prostitute and non-prostitute female drug users in Glasgow, Scotland. Addictive Behaviors, 30(5), 1019-1023.
16. Gilchrist, G., & Gunn, J. (2007). Observational studies of depression in primary care: What do we know? BMC Family Practice, 8, 28.
17. Goldberg, D., & Williams, P. (1988). A user's guide to the general health questionnaire. Windsor, UK: NFER-Nelson.
18. Gossop, M., Marsden, J., Stewart, D., Edwards, C., Lehmann, P., Wilson, A., & Segar, G. (1997). The national treatment outcome research study in the United Kingdom: Six-month follow-up outcomes. Psychology of Addictive Behaviours, 11, 324-337.
19. Hides, L., Lubman, D.I., Devlin, H., Cotton, S., Aitken, C., Gibbie, T., & Hellard, M. (2007). Reliability and validity of the Kessler 10 and Patient Health Questionnaire among injecting drug users. Australian and New Zealand Journal of Psychiatry, 41(2), 166-168.
20. Jacobson, N.S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12-29.
21. Kay-Lambkin, F.J., Baker, A., Lewin, T.J., & Carr, V.J. (2009). Computer-based psychological treatment for comorbid depression and substance use problems: A randomised controlled trial of clinical efficacy. Addiction, 104, 378-388.
22. Kay-Lambkin, F.J., Baker, A.L., Kelly, B., Lewin, T.J., McElduff, P., & Barker, D. (2011). Clinician-assisted computerised versus therapist-delivered treatment for depressive and addictive disorders: Results of a randomised controlled trial. Medical Journal of Australia, 195, S44-S50.
23. Lewis, G., Pelosi, A.J., Araya, R., & Duna, G. (1992). Measuring psychiatric disorders in the community: A standardised assessment for use by lay interviewers. Psychological Medicine, 22, 465-486.
24. Lykke, J., Hesse, M., Austin, S.F., & Oestrich, I. (2008). Validity of the BPRS, the BDI and the BAI in dual diagnosis patients. Addictive Behaviors, 33(2), 292-300.
25. Marsden, J., Farrell, M., Bradbury, C., Dale-Perera, A., Eastwood, B., Roxburgh, M., & Taylor, S. (2008). Development of the treatment outcomes profile. Addiction, 103, 1450-1460.
26. McEvoy, P.M., & Shand, F. (2008). The effect of comorbid substance use disorders on treatment outcome for anxiety disorders. Journal of Anxiety Disorders, 22, 1087-1098.
27. McManus, S., Meltzer, H., Brugha, T., Bebbington, P., & Jenkins, R. (2009). Adult Psychiatric Morbidity in England, 2007: Results of a household survey. The NHS Information Centre for health and social care, National Centre for Social Research and the Department of Health Sciences, University of Leicester.
28. McMillan, D., Richards, D., & Gilbody, S. (2010). Defining successful treatment outcome in depression using the PHQ-9: A comparison of methods. Journal of Affective Disorders, 127, 122-129.
29. McPherson, A., & Martin, C.R. (2011). Is the Hospital Anxiety and Depression Scale (HADS) an appropriate screening tool for use in an alcohol-dependent population? Journal of Clinical Nursing, 20, 1507-1517.
30. Meltzer, H., Gill, B., Petticrew, M., & Hinds, K. (1995). OPCS Surveys of Psychiatric Morbidity. Report 1. The prevalence of psychiatric morbidity among adults aged 16-64 living in private households in Great Britain. London: HMSO.
31. National Treatment Agency for Substance Misuse. (2012). The national drug treatment monitoring System. Retrieved from https://www.ndtms.net/Default.aspx
32. Schmitz, N., Kruse, J., Heckrath, C., Alberti, L., & Tress, W. (1999). Diagnosing mental disorders in primary care: The General Health Questionnaire (GHQ) and the Symptom Check List (SCL-90-R) as screening instruments. Social Psychiatry and Psychiatric Epidemiology, 34, 360-366.
33. Strathdee, G., Manning, V., Best, D., Keaney, F., Bhui, K., Witton, J., . . . Wilson-Jones, C. (2002). Dual diagnosis in a primary care group (PCG): A step-by-step epidemiological needs assessment and design of a training and service response model. London: Department of Health.
34. Weaver, T., Madden, P., Charles, V., Stimson, G., Renton, A., Tyrer, P., . . . Ford, C. (2003). Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry, 183, 304-313.
35. World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: WHO.